By purchasing our Semaglutide Program (Generic Wegovy) you can rest assured that you are working with a qualified weight loss specialist and that your medication will be sourced from a certified pharmacy in the United States.
Doctor Consult: Discuss your treatment plan with one of our licensed doctors
Supplies: All medications and supplies are included, with no hidden fees
Support: Our well-trained medical staff is ready to answer your questions
10% Off for a Limited Time*
WHAT IS SEMAGLUTIDE (GENERIC WEGOVY)?
Semaglutide, also marketed under the brand names Ozempic, Rybelsus and Wegovy, is an FDA-approved injectable for weight loss that mimics the actions of GLP-1, a hormone that targets specific areas of the brain known to suppress hunger.
The Prevail GLP-1 Weight Loss (Semaglutide) Program includes the following:
HEALTH BENEFITS OF THE SEMAGLUTIDE PROGRAM
Semaglutide (Generic Wegovy) is a glucagon-like peptide-1 agonist that promotes weight loss by controlling appetite. Losing excess weight can provide many health benefits, such as:.
HOW DOES SEMAGLUTIDE WORK?
Semaglutide, also known by its generic name Wegovy, is a glucagon-like peptide-1 (GLP-1) agonist used in conjunction with a reduced-calorie diet and exercise to promote sustainable weight loss. It has demonstrated more potent effects compared to other medications in its class, potentially due to its higher dosage. By binding to brain receptors that regulate hunger and appetite, semaglutide alters food preferences and reduces calorie consumption. Its mechanism of action involves delaying stomach emptying and slowing intestinal motility, leading to prolonged satiety. Additionally, GLP-1 agonists stimulate insulin secretion and decrease glucagon release, resulting in lower blood glucose levels.
Several clinical trials evaluated semaglutide’s efficacy and safety in overweight or obese individuals, with or without diabetes. These trials incorporated behavioral interventions like counseling on diet and exercise, as well as meal replacements. The largest trial revealed that the group receiving semaglutide achieved a remarkable 12% more weight loss at 28 weeks compared to the placebo. Semaglutide is particularly beneficial for individuals struggling with appetite control and snacking tendencies.
*Health consent forms, a doctor consultation, and a doctor approval are all required
*Available in all 50 states
*Filled with a 3rd party pharmacy
*10% off only valid for one-time purchase of 3-month program paid-in-full. Offer applies to select pharmacies and states.